Emerson Reports Second Quarter 2014 Results

Emerson (NYSE: EMR) today announced that sales for the second quarter ended March 31, 2014 declined 2 percent, with the Artesyn divestiture deducting 5 percent and acquisitions adding 1 percent. …read more